LifeArc Ventures invests in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases

/PRNewswire/ -- LifeArc Ventures, the investment arm of LifeArc, today announced its participation in a USD $16 million (GBP £13 million) Series A financing...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,London ,City Of ,Lucy Edwardes Jones ,Aneesh Karatt Vellatt ,John Mccafferty ,Tim Funnell ,Sohaib Mir ,Mo Noonan Jonathan Birt ,Maxion Knotbody ,Fairjourney Biologics ,Clare Terlouw Sohaib Mir ,Astrazeneca ,Cambridge Antibody Technology ,Lifearc Ventures ,Monograph Capital ,Arc Ventures ,Senior Investment Principal ,Chief Executive Officer ,Chief Scientific Officer ,Edwardes Jones ,Lifearc ,